Effects of octreotide and propranolol on colonic mucosa in rats with portal hypertensive colopathy

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1352-1355

  Aydede, Hasan ^a,c   Sakarya, Aslan ^a   Erhan, Yamac ^a   Kara, Eray ^a   Ilkgul, Ozer ^a   Ozdemir, Necmettin ^b  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Colon; Octreotide; Portal hypertension; Propranolol; Rats

Indexed keywords

OCTREOTIDE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON DISEASE; COLON HEMORRHAGE; COLON MUCOSA; CONTROLLED STUDY; DRUG EFFECT; EDEMA; HISTOPATHOLOGY; HYPEREMIA; MALE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; GASTROINTESTINAL AGENTS; HYPERTENSION, PORTAL; INTESTINAL MUCOSA; MALE; OCTREOTIDE; PORTAL SYSTEM; PROPRANOLOL; RATS; RATS, INBRED STRAINS; REGIONAL BLOOD FLOW;

EID: 0141763564     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Cheung RC, Cooper S, Keeffe EB: Endoscopic gastrointestinal manifestations of liver disease. Gastrointest Endosc Clin N Am 2001; 11:15-44.
2. Viggiano TR, Gostout CJ: Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic and pathologic features. Am J Gastroenterol 1992; 87:944-954.
3. Tam TN, Lee SD: Colonic mucosal changes in patients with liver cirrhosis. Gastrointest Endosc 1995; 42:408-412.
4. Bini EJ, Lascarides CE, Micale PL, Weinshel EH: Mucosal abnormalities of the colon in patients with portal hypertension: an endoscopic study. Gastrointest Endosc 2000; 52:511-516.
5. Ohasi K, Orihata G, Ohta S, Takamori S, Kojima K, Fukazawa M, et al: Portal hypertensive gastropathy and colopathy. Nippon Rinsho 1998; 56:2369-2375. (In Japanese with English abstract)
6. Yoshie K, Fujita Y, Moriya A, Kawana I, Miyamoto K, Umemura S: Octreotide for severe acute bleeding from portal hypertensive colopathy: a case report. Eur J Gastroenterol Hepatol 2001; 13:1111-1113.
7. Orloff MJ: Portal hypertension and portocaval shunt in Surgical Research. Souba WW, Wilmore DW (Eds.). San Diego California: Academic Press, 2001; pp. 637-701.
8. Bernard AC, Hagihara PF, Burke VJ, Kugelmas M: Endoscopic localization and management of colonic bleeding in patients with portal hypertension. Surg Laparosc Endosc Percutan Tech 2001; 11:195-198.
9. Balzer C, Lotterer E, Kleber G, Fleig WE: Transjugular intrahepatic portosystemic shunt for bleeding angiodysplasia-like lesions in portal hypertensive colopathy. Gastroenterology 1998; 115:167-172.
10. Naveau S, Bedossa P, Poynard T, Mory B, Chaput JC: Portal hypertensive colopathy a new entity. Dig Dis Sci 1991; 36:1774-1781.
11. Gonzalez JFP, Lanuza EDA, Zurita IM, Mendez SM: Portal hypertensive colopathy: histologic appearance of the colonic mucosa. Hepatogastroenterology 1998; 45:40-43.
12. Bosch J, Garcia-Pagan JC: Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32:141-156.
13. D'Amico G, Pagliaro L, Bosch J: Treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:332-354.
14. Garcia N, Sanyal AJ: Portal hypertensive gastropathy and gastric antral vascular ectasia. Curr Treat Options Gastroenterol 2001; 4:163-171.
15. Lin HC, Yang MCM, Hou MC, Li SM, Huang YT, Yu PC, et al: Effect of long-term administration of Ocreotide in portal vein-stenosed rats. Hepatology 1996; 23:537-543.